Clot Management
Payments companies reported to CMS as associated with Clot Management. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Clot Management, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Clot Management
These are the largest totals companies reported as associated with Clot Management. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ilan Rzadkowolsky-Raoli | Brooklyn, NY | Diagnostic Radiology | $38,904.80 |
| Alexander Misono | Newport Beach, CA | Vascular & Interventional Radiology | $31,168.83 |
| Fakhir Elmasri | Lakeland, FL | Vascular & Interventional Radiology | $17,344.16 |
| Jong Ho Park | Lakeland, FL | Vascular & Interventional Radiology | $15,311.59 |
| Aravinda Nanjundappa | Beckley, WV | Interventional Cardiology | $14,973.34 |
| Jason Beaver | Dothan, AL | Surgery | $13,801.07 |
| Lawrence Whitney | Lakeland, FL | Vascular & Interventional Radiology | $10,847.09 |
| Dylan Suttle | Greensboro, NC | Vascular & Interventional Radiology | $10,806.20 |
| Hector Ferral | Evanston, IL | Vascular & Interventional Radiology | $9,841.68 |
| Jacob Cynamon | Bronx, NY | Diagnostic Radiology | $9,150.92 |
Prescribed Clot Management?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.